Primary tabs

Search
Limit to
Export 215 results:
Filters: Author is M. Arbyn
2011
Cytological screening for cervical cancer in the province of Limburg, Belgium., Arbyn, M., Van Nieuwenhuyse An, Bogers Johannes, De Jonge Eric, De Beeck Lode Op, Matheï Catharina, and Buntinx Frank , Eur J Cancer Prev, 2011 Jan, Volume 20, Issue 1, p.18-24, (2011)
Prevention of Cervical Cancer in Belgium: Anno 2011, Arbyn, M., Van Casteren Viviane, and Van Hoof E. , 0/0/2011, Volume 2010/010, Number 118, Brussels, p.118, (2011)
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors., Arbyn, M., Xu L, Simoens Cindy, Martin-Hirsch Pierre Pl, Bryant Andrew, Beutels Philippe, Paraskevaidis Evangelos, van Hoof Elke, Steben Marc, Qiao Youlin, et al. , Cochrane Database Syst Rev, 2011, Volume 2011, Issue 4, (2011)
Prophylactic vaccination of girls and female adolescents against human papilomavirus infection (Belgium, 2007-2009), Arbyn, M., Simoens Cindy, Fabri V., and Swennen Béatrice , 0/0/2011, Number 50, Brussels, p.50, (2011)
Treatment of cervical cancer precursors: influence of age, completeness of excision and cone depth on therapeutic failure, and on adverse obstetric outcomes., Arbyn, M., Simoens Cindy, Goffin F, Noehr B, and Bruinsma F , BJOG, 2011 Sep, Volume 118, Issue 10, (2011)
Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania., Arbyn, M., Antoine Jérôme, Mägi Margit, Smailyte Giedre, Stengrevics Aivars, Suteu Ofelia, Valerianova Zdravka, Bray Freddie, and Weiderpass Elisabete , Int J Cancer, 2011 Apr 15, Volume 128, Issue 8, p.1899-907, (2011)
Worldwide burden of cervical cancer in 2008., Arbyn, M., Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, and Ferlay J , Ann Oncol, 2011 Dec, Volume 22, Issue 12, p.2675-86, (2011)
2010
Analysis of individual health insurance data pertaining to pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium 2002-2006), Arbyn, M., Simoens Cindy, and Fabri V. , 0/9/2010, Brussels, p.125, (2010)
Cervical cytology biobanking in Europe., Arbyn, M., Van Veen Evert-Ben, Andersson Kristin, Bogers Johannes, Boulet Gaëlle, Bergeron Christine, von Knebel-Doeberitz Magnus, and Dillner Joakim , Int J Biol Markers, 2010 Jul-Sep, Volume 25, Issue 3, p.117-25, (2010)
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document., Arbyn, M., Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Herbert A, and von Karsa L , Ann Oncol, 2010 Mar, Volume 21, Issue 3, p.448-58, (2010)
Human papillomavirus-based triage of women showing a cervical cytology result of borderline or mild dyskaryosis., Arbyn, M., Martin-Hirsch P, and Wentzensen N , BJOG, 2010 May, Volume 117, Issue 6, p.641-4, (2010)
Immediate colposcopy referral in women with low-grade abnormal results on cervical cytology detects more CIN2 or worse lesions than cytological surveillance in primary care, but might lead to overtreatment., Arbyn, M., Martin-Hirsch Pierre, and Buntinx Frank , Evid Based Med, 2010 Feb, Volume 15, Issue 1, p.13-4, (2010)
Introduction of human papillomavirus vaccination in Belgium, Luxembourg and the Netherlands., Arbyn, M., Simoens Cindy, Van Damme P, Scharpantgen A, Meijer C J. L. M., and Beutels P , Gynecol Obstet Invest, 2010, Volume 70, Issue 4, p.224-32, (2010)
2009
Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000)., Arbyn, M., Simoens Cindy, Van Oyen Herman, Foidart Jean-Michel, Goffin Frédéric, Simon Philippe, and Fabri Valérie , Prev Med, 2009 May, Volume 48, Issue 5, p.438-43, (2009)
The challenges of organising cervical screening programmes in the 15 old member states of the European Union., Arbyn, M., Rebolj Matejka, De Kok Inge M. C. M., Fender Murielle, Becker Nikolaus, O'Reilly Marian, and Andrae Bengt , Eur J Cancer, 2009 Oct, Volume 45, Issue 15, p.2671-8, (2009)
Description of cervical cancer mortality in Belgium using Bayesian age-period-cohort models., Raifu, A O., and Arbyn M. , Archives of Public Health, Jan-12-2009, Volume 67, Issue 3, (2009)
How to evaluate emerging technologies in cervical cancer screening?, Arbyn, M., Ronco Guglielmo, Cuzick Jack, Wentzensen Nicolas, and Castle Philip E. , Int J Cancer, 2009 Dec 01, Volume 125, Issue 11, p.2489-96, (2009)
International agreement to join forces in synthesizing evidence on new methods for cervical cancer prevention., Arbyn, M., and Cuzick Jack , Cancer Lett, 2009 Jun 08, Volume 278, Issue 1, p.1-2, (2009)
Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008., Simoens, Cindy, Sabbe Martine, Van Damme P, Beutels P, and Arbyn M. , Euro Surveill, 2009 Nov 19, Volume 14, Issue 46, (2009)
Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium., Arbyn, M., Benoy Ina, Simoens Cindy, Bogers Johannes, Beutels Philippe, and Depuydt Christophe , Cancer Epidemiol Biomarkers Prev, 2009 Jan, Volume 18, Issue 1, p.321-30, (2009)
Trends of cervical cancer mortality in the member states of the European Union., Arbyn, M., Raifu Amidu O., Weiderpass Elisabete, Bray Freddie, and Anttila Ahti , Eur J Cancer, 2009 Oct, Volume 45, Issue 15, p.2640-8, (2009)
Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate., Arbyn, M., Martin-Hirsch Pierre, Buntinx Frank, Van Ranst Marc, Paraskevaidis Evangelos, and Dillner Joakim , J Cell Mol Med, 2009 Apr, Volume 13, Issue 4, p.648-59, (2009)

QR code

QR code for this page URL